Tata Elxsi and Google Lead India’s AI Revolution in Medical Imaging and Diagnostics
As artificial intelligence (AI) increasingly reshapes healthcare worldwide, Tata Elxsi, the innovation arm of the Tata Group, is leading a transformation in India’s medical imaging sector using cutting-edge AI technologies. Concurrently, Google’s strategic partnerships with Indian medical device startups like Forus Health and AuroLab underscore a growing private-sector drive to scale AI-powered diagnostic solutions across the country. Tata Elxsi’s AI…
Trending
Pune’s Medical Mystery Solved: Norovirus Outbreak the Cause of Paralysis.
Generative AI Advances Fast-Track Discovery of Life-Saving Antibiotics
Ayurvedic Diabetes Treatment: A Doctor’s Evidence Based Integrated Medicine Guide
AI Diagnostics Hospital Mumbai: Nita Ambani Unveils Revolutionary 2,000-Bed Medical City Transforming Healthcare
Editorial picks
Tata Elxsi and Google Lead India’s AI Revolution in Medical Imaging and Diagnostics
As artificial intelligence (AI) increasingly reshapes healthcare worldwide, Tata Elxsi, the innovation arm of the Tata Group, is leading a transformation in India’s medical imaging sector using cutting-edge AI technologies. Concurrently, Google’s strategic partnerships with Indian medical device startups like Forus Health and AuroLab underscore a growing private-sector drive to…
Ayurvedic Diabetes Treatment: A Doctor’s Evidence Based Integrated Medicine Guide
AI Diagnostics Hospital Mumbai: Nita Ambani Unveils Revolutionary 2,000-Bed Medical City Transforming Healthcare
Fermented Foods for Digestive Health After Antibiotics: The Science-Backed Recovery Guide
🏥 Affordable Healthcare Abroad: The Ultimate Guide 2025
Categories
In the Spotlight
Russia’s EnteroMix: First Personalized mRNA Cancer Vaccine in Clinical Testing
Russian health authorities are on the verge of introducing a breakthrough personalized cancer vaccine Russia has developed, named EnteroMix. Created by the National Medical Research Radiological Centre (NMRRC) in collaboration with leading Russian institutions including the Gamaleya Center, the vaccine represents a major mRNA oncology breakthrough and is now in Phase 1 clinical testing with highly promising results. Clinical Testing…
